Experiment 363100
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Panax ginseng (ARALIACEAE) |
| Citation | SRISURAPANON,S: APIBAL,S: SIRIPOL,R: RUNGROENG,K: CHERDRUGSI,P: VANICH-ANGKUL,V: TIMVIPARK,C:. (1997). THE EFFECT OF STANDARDIZED GINSENG EXTRACT ON PERIPHERAL BLOOD LEUKOCYTES AND LYMPHOCYTE SUBSETS: A PRELIMINARY STUDY IN YOUNG HEALTHY ADULTS.. 80(1) |
| Amount utilized | |
| Compound isolated | |
| Disease | A STUDY WAS UNDERTAKEN IN TWENTY YOUNG, HEALTHY THAI MALES TO INVESTIGATE THE EFFECTS OF PROLONGED ADMINISTRATION OF STANDARDIZED GINSENG EXTRACT ON PERIPHERAL BLOOD LEUKOCYTES AND LYMPHOCYTE SUBSETS. THE SUBJECTS WERE DIVIDED INTO TWO EQUAL GROUPS AS GINSENG AND PLACEBO GROUPS. THE FIRST GROUP RECEIVED TWO CAPSULES DAILY OF STANDARDIZED GINSENG EXTRACT 150 MG PER CAPSULE FOR 8 WKS. THE SECOND GROUP RECEIVED PLACEBO AND SERVED AS CONTROL. CIRCULATORY LEVELS OF TOTAL AND DIFFERENTIAL LEUKOCYTE COUNTS AND PERCENTAGE OF LYMPHOCYTE SUBSETS WERE DETERMINED PRIOR TO AND AT THE 4TH AND 8TH WK OF THE EXPERIMENTAL PERIOD. THERE WERE NO SIGNIFICANT DIFFERENCES IN THE TOTAL AND DIFFERENTIAL LEUKOCYTE COUNTS AS WELL AS THE LYMPHOCYTE SUBPOPULATIONS: CD3 (T CELLS), CD 19 (B CELLS), CD4 (T-HELPER CELLS), CD8 (T-SUPPRESSION CELLS), CD4/CD8 RATIO, AND CD25 (INTERLEUKIN-2-RECEPTOR CELLS) BETWEEN THE TWO SUBJECT GROUPS THROUGHOUT THE EXPERIMENTAL PERIOD. CONCLUSION: ORAL ADMINISTRATION OF STANDARDIZED GINSENG EXTRACT, 300 MG/DAY FOR 8 WKS CAUSED NO SIGNIFICANT CHANGES IN PERIPHERAL BLOOD LEUKOCYTES AND LYMPHOCYTE SUBSETS IN YOUNG, HEALTHY THAI MALES. |
| Dose amount | 300.0 MG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | ROOT |
| Gender | MALE |